000120390 001__ 120390
000120390 005__ 20240228135019.0
000120390 0247_ $$2doi$$a10.1038/leu.2013.244
000120390 0247_ $$2pmid$$apmid:23958921
000120390 0247_ $$2ISSN$$a0887-6924
000120390 0247_ $$2ISSN$$a1476-5551
000120390 0247_ $$2altmetric$$aaltmetric:1701980
000120390 037__ $$aDKFZ-2017-00823
000120390 041__ $$aeng
000120390 082__ $$a610
000120390 1001_ $$0P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5$$aHillengass, Jens$$b0$$eFirst author$$udkfz
000120390 245__ $$aPrognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance.
000120390 260__ $$aBasingstoke$$bNature Publ. Group$$c2014
000120390 3367_ $$2DRIVER$$aarticle
000120390 3367_ $$2DataCite$$aOutput Types/Journal article
000120390 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1495100492_14042
000120390 3367_ $$2BibTeX$$aARTICLE
000120390 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120390 3367_ $$00$$2EndNote$$aJournal Article
000120390 520__ $$aRadiological skeletal survey or computed tomography are currently applied to assess bone diseases in patients with monoclonal plasma cell disorders. Whole-body magnetic resonance imaging (whole-body MRI) allows detecting the infiltration of clonal cells in nearly the whole bone marrow compartment even before bone destruction has occurred. Those MRI results (i.e., patterns of bone marrow infiltration) have been demonstrated to be of prognostic significance in patients with symptomatic as well as asymptomatic multiple myeloma. We have therefore analyzed the findings of whole-body MRI in 137 consecutive individuals with monoclonal gammopathy of undetermined significance (MGUS). A focal infiltration pattern was detected in 23.4% of patients. Presence and number of focal lesions as well as value of M-Protein were of independent prognostic significance for progression into a symptomatic disease requiring systemic treatment (P=0.02; P<0.0001 and P=0.0005, respectively). Lower homogeneous signal intensities in T1-weighted images were related to a physiologically higher bone marrow cellularity in younger individuals (P=0.002). We conclude that whole-body MRI identifies patients with focal accumulations of presumably monoclonal cells in bone marrow with prognostic impact concerning the risk of progression into symptomatic disease.
000120390 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000120390 588__ $$aDataset connected to CrossRef, PubMed,
000120390 7001_ $$0P:(DE-HGF)0$$aWeber, M-A$$b1
000120390 7001_ $$aKilk, K.$$b2
000120390 7001_ $$aListl, K.$$b3
000120390 7001_ $$0P:(DE-HGF)0$$aWagner-Gund, B.$$b4
000120390 7001_ $$aHillengass, M.$$b5
000120390 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b6$$udkfz
000120390 7001_ $$aFarid, A.$$b7
000120390 7001_ $$aNeben, K.$$b8
000120390 7001_ $$0P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDelorme, Stefan$$b9$$udkfz
000120390 7001_ $$aLandgren, O.$$b10
000120390 7001_ $$0P:(DE-He78)a1aa959d47e3e026abe157a8adf24b96$$aGoldschmidt, Hartmut$$b11$$eLast author$$udkfz
000120390 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/leu.2013.244$$gVol. 28, no. 1, p. 174 - 178$$n1$$p174 - 178$$tLeukemia$$v28$$x1476-5551$$y2014
000120390 909CO $$ooai:inrepo02.dkfz.de:120390$$pVDB
000120390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000120390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000120390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000120390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000120390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000120390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1aa959d47e3e026abe157a8adf24b96$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000120390 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000120390 9141_ $$y2014
000120390 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120390 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120390 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2015
000120390 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120390 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000120390 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000120390 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000120390 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000120390 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000120390 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000120390 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000120390 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000120390 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bLEUKEMIA : 2015
000120390 9201_ $$0I:(DE-He78)E013-20160331$$kE013$$lHämatoonkologische Bildgebung$$x0
000120390 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lRadiologie$$x1
000120390 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x2
000120390 980__ $$ajournal
000120390 980__ $$aVDB
000120390 980__ $$aI:(DE-He78)E013-20160331
000120390 980__ $$aI:(DE-He78)E010-20160331
000120390 980__ $$aI:(DE-He78)C060-20160331
000120390 980__ $$aUNRESTRICTED